1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pharmaceutical Technologies Grant is sponsored by NSF SBIR. NSF funds startups to create pharmaceutical technologies. This program supports drug discovery and manufacturing, but not clinical studies, clinical validation of information technologies or medical devices, or studies performed primarily for regulatory purposes.
Get alerted about grants like this
Save a search for “NSF SBIR” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Pharmaceutical Technologies Grant – Apply Today | NSF SBIR Check recent critical alerts! (Last updated 4/16/2026) NSF will resume the submission of new Project Pitches to the SBIR/STTR programs in the coming weeks. Program Directors will continue to process Project Pitches that were previously received.
Please direct any questions to sbir@nsf. gov . Pharmaceutical Technologies (PT) The Neural Analytics Lucid™ M1 transcranial Doppler Ultrasound System is indicated as an adjunct to the standard clinical practices for measuring and displaying cerebral blood flow velocity within the major conducting arteries and veins of the head and neck.
Additionally, the Lucid™ M1 System measures the occurrence of transient emboli signals within the blood stream.
Pharmaceutical Technologies (PT) The Pharmaceutical Technologies topic covers a wide range of technology areas that advance the discovery, formulation, and manufacture of novel drugs, moieties, compounds, products, processes, platforms or services that will improve the selection, quality or price of pharmaceutical and biologic therapies.
The Pharmaceutical Technologies topic is not aimed at supporting or conducting clinical trials, clinical efficacy and safety studies, the development of pre-clinical or clinical-stage drug candidates, work on medical devices or schedule I substances, or work performed primarily for regulatory purposes.
Limited studies with human subjects may be acceptable if they are performed in support of feasibility, proof-of-concept studies of early-stage technologies and must follow NSF policies on research on human subjects . Proposals that request support for clinical studies are noncompliant with the SBIR/STTR solicitations and returned without review.
The NSF SBIR/STTR program no longer supports the development of specific therapeutic molecules. Drug Discovery and Manufacturing are still supported by the program. Subtopics are not aimed at supporting clinical trials, the clinical validation of information technologies, or medical devices or studies performed primarily for regulatory purposes.
Limited studies with human subjects may be acceptable to the extent that they are performed in support of feasibility, such as proof-of-concept studies of early-stage technologies. Proposals that request support for clinical studies will be deemed noncompliant with the SBIR/STTR solicitations and returned without review. PT2.
Pharmaceutical and Biologic Manufacturing PT3. Other Pharmaceutical Technologies Application process for Pharmaceutical Technologies (PT) funding Eligibility for Pharmaceutical Technologies (PT) funding + Your company must be a small business (fewer than 500 employees) located in the United States. At least 50% of your company’s equity must be owned by U.S. citizens or permanent residents.
NSF does not fund companies that are majority-owned by multiple venture capital firms, private equity firms, or hedge funds, to participate in SBIR and STTR. All funded work, including work done by consultants and contractors, needs to take place in the United States. The project’s principal investigator (tech lead) must be legally employed at least 20 hours a week by the company seeking funding.
The principal investigator doesn’t need any advanced degrees. The principal investigator needs to commit to at least one month (173 hours) of work on a funded project per six months of project duration. Evaluation Criteria: What We Look for When Evaluating Pharmaceutical Technologies (PT) proposals + Take our project assessment to see if your work might be a good fit for NSF funding.
Detecting biological contaminants in water & pharmaceuticals Spheryx, Inc. created a technology to monitor, count and characterize microscopic particles in a variety of fluids, such as water, chemicals, or even pharmaceuticals. To learn more visit: https://spheryx.
solutions/ New drug delivery technology for tumor treatment – Tambo Tambo developed a new technology to activate drugs at specific locations within the body to treat diseases with lower doses of drugs and fewer toxic side effects. To learn more visit: https://www. shasqi.
com/ SQZ Biotechnologies Company nanoView Diagnostics Inc. Novome Biotechnologies, Inc. Protein Dynamic Solutions, Inc. We invest up to $2 million in seed funding and take zero equity. We’re looking for companies that are transformative, high-risk, have a market pull, and are scaleable.
Based on current listing details, eligibility includes: Small businesses (fewer than 500 employees) located in the United States, with at least 50% equity owned by U. S. citizens or permanent residents. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
The purpose of this FOA is to provide funding for up to four (4) Tribal Colleges and Universities (TCUs) that will provide entrepreneurial development services to Native American communities, focusing on supplying services to socially and economically disadvantaged entrepreneurs in locations that are outside of the geographical areas of existing SBA resources. Eligible applicants must be Tribal Colleges and Universities as defined in the Higher Education Act HEA 316 (U.S.C. 1059c). Funding Opportunity Number: SB-GC7J-23-002. Assistance Listing: 59.007. Funding Instrument: G. Category: BC,ED. Award Amount: Up to $250K per award.
The purpose of this FOA is to provide funding for up to two (2) private, non-profit organizations that will provide entrepreneurial development services to women, with an emphasis on socially and economically disadvantaged entrepreneurs in locations that are outside of the geographical areas of existing WBCs for the District of Columbia (DC) and the State of Oregon. There will be one award for each location. Eligible applicants must be private, non-profit organizations with 501(c) tax exempt status from the U.S. Treasury’s Internal Revenue Service and must provide services to the District of Columbia (DC) and State of Oregon. Funding Opportunity Number: SB-OEDWB-23-002. Assistance Listing: 59.043. Funding Instrument: G. Category: BC,CD,RD. Award Amount: $75K – $150K per award.
Small Business Innovation Research and Small Business Technology Transfer Programs Phase I is sponsored by U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA). The USDA SBIR/STTR programs support small businesses in creating innovative, disruptive technologies with commercial potential or societal benefit, including projects dealing with agriculturally-related manufacturing and alternative and renewable energy technologies. Specialty tubing could be relevant for agricultural equipment or renewable energy systems.
NSF SBIR uses a unique Project Pitch system for Phase I. Here is how to submit a compelling pitch after the reauthorization restart, with tips for AI and deep tech startups.
Read articleA step-by-step guide for AI startup founders applying to NSF SBIR/STTR: topic areas, Phase I vs II, award amounts, success rates, and what NSF reviewers actually want.
Read article